In this episode, we discuss AI drug discovery hype, agent security risks, and why pharma's AI workforce bets remain unproven.
Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part Two
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Pfizer's 8-Month Path from Candidate to IND: AAPS PharmSci 360 2026
5